Concerns about exercise are related to walk test results in pulmonary rehabilitation for patients with COPD.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3277820)

Published in Int J Behav Med on March 01, 2012

Authors

Maarten J Fischer1, Margreet Scharloo, Jannie Abbink, Alex van 't Hul, Dirk van Ranst, Arjan Rudolphus, John Weinman, Klaus F Rabe, Adrian A Kaptein

Author Affiliations

1: Medical Psychology, Leiden University Medical Center (LUMC), P.O. Box 9555, 2300, RB, Leiden, the Netherlands. m.j.fischer@lumc.nl

Articles cited by this

The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86

Psychophysical bases of perceived exertion. Med Sci Sports Exerc (1982) 30.13

The Health Belief Model: a decade later. Health Educ Q (1984) 25.48

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01

The 6-min walk test: a quick measure of functional status in elderly adults. Chest (2003) 4.29

Six minute walking distance in healthy elderly subjects. Eur Respir J (1999) 3.56

Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15

Patient adherence in COPD. Thorax (2008) 2.85

Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res (2008) 2.16

Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.97

Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82

Six minute walk distance in healthy subjects aged 55-75 years. Respir Med (2005) 1.64

Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61

Achieving asthma control in practice: understanding the reasons for poor control. Respir Med (2008) 1.61

Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax (1994) 1.51

Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res (1999) 1.47

Predictors of success and failure in pulmonary rehabilitation. Eur Respir J (2006) 1.43

Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.42

The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest (2007) 1.41

Fear of movement and (re)injury in chronic musculoskeletal pain: Evidence for an invariant two-factor model of the Tampa Scale for Kinesiophobia across pain diagnoses and Dutch, Swedish, and Canadian samples. Pain (2007) 1.38

Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs. J Pediatr Psychol (2009) 1.30

Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med (2007) 1.25

Investigation of elevated fear-avoidance beliefs for patients with low back pain: a secondary analysis involving patients enrolled in physical therapy clinical trials. J Orthop Sports Phys Ther (2008) 1.23

Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med (2009) 1.19

Assessing patients' beliefs about cardiac rehabilitation as a basis for predicting attendance after acute myocardial infarction. Heart (2006) 1.17

Behavioral exercise programs in the management of chronic obstructive pulmonary disease. J Consult Clin Psychol (1984) 1.13

The anxiety sensitivity index: item analysis and suggestions for refinement. J Pers Assess (2001) 1.08

Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res (2010) 1.07

Participation and drop-out in pulmonary rehabilitation: a qualitative analysis of the patient's perspective. Clin Rehabil (2007) 1.06

Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil (2001) 1.05

Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. J Psychosom Res (2009) 1.03

The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation. Respir Med (2007) 0.97

The relationship of anticipated pain and fear avoidance beliefs to outcome in patients with chronic low back pain who are not receiving workers' compensation. Spine (Phila Pa 1976) (2005) 0.95

The effect of a pulmonary rehabilitation program on self-efficacy, perception of dyspnea, and physical endurance. Heart Lung (1997) 0.90

Is the theory of planned behavior a useful framework for understanding exercise adherence during phase II cardiac rehabilitation? J Cardiopulm Rehabil (2003) 0.90

Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2005) 0.89

Predictors of improvement in the 12-minute walking distance following a six-week outpatient pulmonary rehabilitation program. Chest (1991) 0.88

Study of energy expenditure during activities of daily living using and not using body position recommended by energy conservation techniques in patients with COPD. Chest (2006) 0.84

Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. Eur Respir J (1998) 0.81

Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2006) 0.80

Articles by these authors

Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med (2011) 7.92

The brief illness perception questionnaire. J Psychosom Res (2006) 6.98

Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet (2004) 6.17

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (2009) 4.40

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet (2009) 4.29

Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19

From COPD to chronic systemic inflammatory syndrome? Lancet (2007) 4.13

Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA (2010) 4.08

Management of non-small-cell lung cancer: recent developments. Lancet (2013) 3.51

Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA (2013) 3.13

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med (2002) 2.97

Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med (2005) 2.78

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med (2004) 2.77

Patient-centredness in chronic illness: what is it and does it matter? Patient Educ Couns (2003) 2.66

A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56

Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. Chest (2013) 2.42

Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med (2009) 2.37

Illness perceptions of low back pain patients in primary care: what are they, do they change and are they associated with outcome? Pain (2008) 2.27

Treating COPD--the TORCH trial, P values, and the Dodo. N Engl J Med (2007) 2.26

Systemic manifestations of COPD. Chest (2011) 2.25

Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother (2005) 2.18

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol (2003) 2.15

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13

The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02

The Asthma-COPD Overlap Syndrome. N Engl J Med (2015) 1.99

Inaccuracy of estimating peak work rate from six-minute walk distance in patients with COPD. COPD (2012) 1.98

The use and reporting of cluster analysis in health psychology: a review. Br J Health Psychol (2005) 1.91

Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85

Social support predicts survival in dialysis patients. Nephrol Dial Transplant (2006) 1.84

Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS (2004) 1.84

The 'Medical Interview Satisfaction Scale' (MISS-21) adapted for British general practice. Fam Pract (2002) 1.81

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80

A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol (2008) 1.80

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One (2011) 1.78

A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol (2011) 1.74

Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A (2004) 1.72

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2009) 1.70

EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer (2008) 1.69

Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.68

Why illness perceptions matter. Clin Med (2007) 1.65

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax (2007) 1.62

Illness beliefs predict disability in rheumatoid arthritis. J Psychosom Res (2009) 1.62

EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience. J Thorac Oncol (2009) 1.60

The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res (2005) 1.59

Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure? Am J Respir Crit Care Med (2003) 1.56

Perceived stress and cortisol levels predict speed of wound healing in healthy male adults. Psychoneuroendocrinology (2004) 1.52

Motivations, outcomes, and characteristics of unspecified (nondirected altruistic) kidney donors in the United Kingdom. Transplantation (2014) 1.49

Health Psychology: the Search for Pathways between Behavior and Health. Annu Rev Psychol (2008) 1.44

High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs. Eur Respir J (2012) 1.43

An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol (2007) 1.40

Analysis of subcarinal lymph nodes in (suspected) non-small-cell lung cancer after a negative transbronchial needle aspiration -- what's next? A preliminary report. Respiration (2005) 1.39

Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies. Respiration (2015) 1.39

Drug safety in COPD revisited: what is the number needed to analyze? Chest (2012) 1.38

Point: were industry-sponsored roflumilast trials appropriate? Yes. Chest (2014) 1.36

Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners. Eur J Pain (2006) 1.35

Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med (2004) 1.34

Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2005) 1.33

Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res (2009) 1.33

Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol (2002) 1.30

Endosonography for lung cancer staging: one scope fits all? Chest (2010) 1.30

Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis (2008) 1.27

Informing participants of allocation to placebo at trial closure: postal survey. BMJ (2002) 1.26

Diaphragm plication in adult patients with diaphragm paralysis leads to long-term improvement of pulmonary function and level of dyspnea. Eur J Cardiothorac Surg (2007) 1.26

Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA (2005) 1.24

Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol Genomics (2005) 1.23

The uncertain consultation and patient satisfaction: the impact of patients' illness perceptions and a randomized controlled trial on the training of physicians' communication skills. Psychosom Med (2005) 1.22

A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med (2004) 1.21

Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol (2008) 1.21

Time orientation and health-related behaviour: measurement in general population samples. Psychol Health (2009) 1.20

Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol (2006) 1.20

Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med (2009) 1.19

Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol (2002) 1.19

A vision statement on guideline development for respiratory disease: the example of COPD. Lancet (2008) 1.18

Illness perceptions predict attendance at cardiac rehabilitation following acute myocardial infarction: a systematic review with meta-analysis. J Psychosom Res (2006) 1.17

Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir Res (2005) 1.17

The patients' illness perceptions and the use of primary health care. Psychosom Med (2005) 1.17

Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med (2013) 1.15

Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc Drugs Ther (2004) 1.15

Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med (2013) 1.14

Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol (2005) 1.12

Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol (2003) 1.11

Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer (2003) 1.09

Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respir Med (2005) 1.09

Can genetic risk information enhance motivation for smoking cessation? An analogue study. Health Psychol (2006) 1.08

Phosphodiesterase-4 inhibitor therapy for lung diseases. Am J Respir Crit Care Med (2013) 1.08

Improving haemodialysis patients' understanding of phosphate-binding medication: a pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment. Br J Health Psychol (2008) 1.07

Illness and treatment beliefs in head and neck cancer: is Leventhal's common sense model a useful framework for determining changes in outcomes over time? J Psychosom Res (2007) 1.07

Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res (2010) 1.06

Perceived stress, stress attributions and psychological distress in psoriasis. J Psychosom Res (2004) 1.06

Quality of life and illness perceptions in patients with recently diagnosed head and neck cancer. Head Neck (2005) 1.06

What is chronic illness? Chronic Illn (2005) 1.05

Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors. Eur J Pharmacol (2006) 1.05

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma. Radiat Oncol (2007) 1.04